Zobrazeno 1 - 10
of 581
pro vyhledávání: '"Sodium zirconium cyclosilicate"'
Autor:
Roberto Alcázar-Arroyo, Maria G. Crespo-Leiro, Jordi Bover, Juan Oliva, Miren Sequera-Mutiozabal, Simona Gradari, Anisia Marinez-Lopez, Blanca Lopez-Chicheri, Neus Vidal-Vilar, Susana Aceituno, Marta Cobo
Publikováno v:
Nefrología, Vol 44, Iss 5, Pp 709-720 (2024)
Resumen: Antecedentes y objetivo: La hiperpotasemia (HK) es una alteración electrolítica en la concentración de iones potasio (K+), cuyo riesgo aumenta en pacientes con enfermedad renal crónica (ERC) o insuficiencia cardiaca (IC) y/o en pacientes
Externí odkaz:
https://doaj.org/article/fd4e9f4a90be4f28882f0b5a0fc9715f
Autor:
Nan Shen, Lihong Zhang, Jing Yang, Yongqiang Lin, Xinyu Liu, Xudong Cai, Juan Cao, Qiang Zhu, Xun Luo, Xin Wan, Henglan Wu, Jianming Ye, Chunyan Shan, Hua Xie, Yifan Wu, Yanping Cao, Jianmin Wang, Xiaoyong Yu, Huimin Wang, Jingdong He, Shaojiang Tian, Fenglei Wu, Xinxin Jiang, Lu Li, Li Zuo, Zhaohua Wang, Changying Xing, Xun Yin, Jianrong Zhao, Cong Ma, Gang Long, Qing Li, Yao Hu, Yifan Shi, Hong-Li Lin
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Externí odkaz:
https://doaj.org/article/9661fb432fcd4162852afee094820ebe
Autor:
Sara Abou Sherif, Irene Katsaiti, Hannah Jebb, Serena Banh, Rachna Bedi, Jeremy Levy, David Thomas, Damien Ashby, Richard Corbett
Publikováno v:
Clinical Medicine, Vol 24, Iss 4, Pp 100222- (2024)
Inpatient treatment of hyperkalaemia with insulin and dextrose can be complicated by iatrogenic hypoglycaemia. We sought to assess the incidence of hypoglycaemia in hospitalised patients with renal disease and assess the impact of the introduction of
Externí odkaz:
https://doaj.org/article/810359b5cbe0471091ab520d97ece9d7
Autor:
Nan Shen, Lihong Zhang, Jing Yang, Yongqiang Lin, Xinyu Liu, Xudong Cai, Juan Cao, Qiang Zhu, Xun Luo, Xin Wan, Henglan Wu, Jianming Ye, Chunyan Shan, Hua Xie, Yifan Wu, Yanping Cao, Jianmin Wang, Xiaoyong Yu, Huimin Wang, Jingdong He, Shaojiang Tian, Fenglei Wu, Xinxin Jiang, Lu Li, Li Zuo, Zhaohua Wang, Changying Xing, Xun Yin, Jianrong Zhao, Cong Ma, Gang Long, Qing Li, Yao Hu, Yifan Shi, Hongli Lin
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Introduction: Sodium zirconium cyclosilicate (SZC) is a nonabsorbed cation-exchanger approved in China for the treatment of hyperkalemia [HK; serum potassium (sK+) levels >5.0 mmol/L]. This is the first real-world study aimed to assess the effectiven
Externí odkaz:
https://doaj.org/article/43dc78eb38894e66940201e1fbab25d1
Autor:
Duo Li, Yan Zhang, Yuansen Chen, Bofan Yang, Jianwen Chen, Jie Shi, Xiaoqin Guo, Yanqing Liu, Li Zhang, Qi Lv, Haojun Fan
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Background: Crush Syndrome (CS), a severe trauma resulting from prolonged muscle compression, is commonly seen in large-scale disasters such as earthquakes. It not only causes localized tissue damage but also triggers electrolyte imbalances, particul
Externí odkaz:
https://doaj.org/article/b69d4f5db54e40f3a57fd3abb179af4c
Autor:
Alberto Ortiz, Carmen del Arco Galán, José Carlos Fernández-García, Jorge Gómez Cerezo, Rosa Ibán Ochoa, Julio Núñez, Francisco Pita Gutiérrez, Juan F. Navarro-González
Publikováno v:
Nefrología, Vol 43, Iss 6, Pp 765-782 (2023)
Resumen: La hiperpotasemia es una alteración electrolítica frecuente con consecuencias potencialmente graves a corto, medio y largo plazo, tanto en términos de morbilidad y mortalidad como de consumo de recursos del Sistema Nacional de Salud. El a
Externí odkaz:
https://doaj.org/article/c140f2093def4977a7a68701e923eee5
Publikováno v:
Journal of Pharmacy & Pharmaceutical Sciences, Vol 26 (2023)
Hyperkalemia is a common electrolyte disorder in patients with chronic kidney disease (CKD) that increases in prevalence with the decline of glomerular fltration rate (GFR). Another risk of hyperkalemia is the use of renin-angiotensin-aldosterone sys
Externí odkaz:
https://doaj.org/article/754e3d1617bf480aa335ed61423da6a9
Publikováno v:
Frontiers in Public Health, Vol 11 (2023)
ObjectivesHyperkalemia most commonly develops in chronic kidney disease (CKD) or heart failure (HF) patients. Sodium zirconium cyclosilicate (SZC) is a new selective potassium (K+) binder for treating hyperkalemia. The aim of this study was to evalua
Externí odkaz:
https://doaj.org/article/e5ee8dbda2f744539007b1d4c26c942f
Publikováno v:
Renal Failure, Vol 45, Iss 2 (2023)
Sodium Zirconium Cyclosilicate (SZC) is commonly used for treating hyperkalemia because it sequesters gastrointestinal potassium ions, thereby reducing serum potassium levels. However, a less-discussed aspect of SZC is its radiopacity on x-ray-based
Externí odkaz:
https://doaj.org/article/668f0ab8ae93494392eedc96fdfeccee
Autor:
Alejandro E. Cañas, Hayden R. Troutt, Luohua Jiang, Sam Tonthat, Omar Darwish, Antoney Ferrey, Shahram Lotfipour, Kamyar Kalantar-Zadeh, Ramy Hanna, Wei Ling Lau
Publikováno v:
BMC Nephrology, Vol 24, Iss 1, Pp 1-11 (2023)
Abstract Background The KBindER (K+ Binders in Emergency Room and hospitalized patients) clinical trial is the first head-to-head evaluation of oral potassium binders (cation-exchange resins) for acute hyperkalemia therapy. Methods Emergency room and
Externí odkaz:
https://doaj.org/article/39eddc3039f04b63924a910384f854e8